RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Brain scans for early Parkinson's changes

Researchers are combining imaging methods to investigate brain chemical pathways before or early in Parkinson's.

Research study · Study reference: ChiCTR2200064368

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported date)
2022-10-01

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Ages 21 to 80 · Ask the team who can join

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: both

Inclusion criteria: The PD high-risk group was set as subjects meeting the probability of PD prodromal phase>80%, and the calculation method of PD prodromal disease probability was based on the 2019 ""Chinese Expert Consensus on Diagnostic Research Standards for Parkinson's Disease Prodromal Phase"". Inclusion criteria: Those with a family history of PD, obvious anosmia, intractable constipation, sleep disturbance, depression, anxiety, cardiac autonomic symptoms, visual impairment, cognitive changes, apathy and other personality changes, as well as those with partial Parkinson's disease symptoms and Signs, PD prodromal probability > 80%, but not yet meet the diagnostic criteria of the British Parkinson's Association Brain Bank. Inclusion criteria for patients in the clinical stage of PD: The neurologists strictly follow the diagnostic criteria for primary PD formulated by the British PD Association Brain Bank to determine the diagnosis of primary Parkinson's disease and secondary Parkinson's syndrome, and pass the unified Parkinson's disease diagnosis. Parkinson's disease rating scale (UPDRS) score and Hoehn&Yahr classification were used for grading. Exclusion criteria: Exclusion criteria included patients with history of severe craniocerebral trauma, history of cerebrovascular disease, history of encephalitis, severe mental symptoms, patients with brain tumors, patients who had been taking long-term medication at the first visit, patients with claustrophobia, patients with contraindications to magnetic resonance scanning, and routine brain MR examinations Those who showed obvious abnormal signals in the brainstem and cervical spinal cord.
Full study name & original research details

Official study title

The neurotransmitter changes related to the substantia nigrostriatal pathway in the early diagnosis and pathogenesis of Parkinson's disease based on multimodal MR imaging

Original description

Intervention: Gold Standard:The PD high-risk group is set as the subjects who meet the probability of PD prodromal phase>80%, and the calculation method of PD prodromal disease probability refers to the 2019 ""Chinese Expert Consensus on Diagnostic Research Standards for Parkinson's Disease Prodromal Phase"".;Index test:NM-MRI; MEGA-PRESS; PRESS; Primary outcome: NM-MRI;Edited MRS;PRESS;

Conditions reported: Parkinson disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Not reported
Interventions
Gold Standard:The PD high-risk group is set as the subjects who meet the probability of PD prodromal phase>80%, and the calculation method of PD prodromal disease probability refers to the 2019 ""Chinese Expert Consensus on Diagnostic Research Standards for Parkinson's Disease Prodromal Phase"".;Index test:NM-MRI; MEGA-PRESS; PRESS;
Phases
Diagnostic New Technique Clincal Study
Sponsor
Shandong Provincial Hospital Affiliated to Shandong First Medical University
Start date reported by registry
2022-10-01 (reported)

Registry updated: Not reported · Status last verified by the registry submitter: Not reported

Registry records retrieved 2026-10-14 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Guangbin Wang · +86 13806408986 · wgb7932596@hotmail.com

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

Facility not reported

China

Status not reported

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.